The Relation Between Serum-based Systemic Inflammatory Biomarkers and Locoregional Lymph Node Metastasis in Clinical Stages I to II Right-sided Colon Cancers: The Role of Platelet-to-Lymphocyte Ratio
- PMID: 37725826
- DOI: 10.1097/SLE.0000000000001228
The Relation Between Serum-based Systemic Inflammatory Biomarkers and Locoregional Lymph Node Metastasis in Clinical Stages I to II Right-sided Colon Cancers: The Role of Platelet-to-Lymphocyte Ratio
Abstract
Background: It aimed to evaluate the relationship between the systemic inflammatory markers and the lymph node metastasis in clinical stages I to II right-sided colon cancers.
Patients and methods: A total of 51 eligible clinical stages I to II right-side located colon cancer patients were included in the study. Complete mesocolic excision and central vascular ligation procedures were performed in all cases. All the patients were divided into 2 main groups, pN - (n = 22) and pN + (n = 29). Demographic parameters, preoperative serum-based inflammatory biomarkers, and histopathological findings were compared between the groups.
Results: The mean age was 61.0 (54 to 71) years. Of the patients, 51.0% (26/51) were females. The open surgical approach was performed on 54.9% (28/51) of the patients and 45.1% (23/51) was performed laparoscopy. The mean total number of retrieved lymph nodes was 29.1. The lympho-vascular invasion was significantly higher in the pN + group (89.7% vs 50.0%). There were no significant differences in neutrophil-to-lymphocyte ratio, C-reactive protein-to-albumin ratio, mean platelet volume-to-platelet ratio, hemoglobine-albuminelymphocyte-platelet score, systemic inflammation index, lymphocyte-to-monocyte ratio, neutrophil-to-monocyte ratio, lymphocyte-to-C-reactive protein ratio (LCR), neutrophil-to-albumin ratio, and prognostic nutritional index. However, the mean platelet-to-lymphocyte ratio (PLR) was significantly lower in the pN + group (pN - : 282.1 vs pN + : 218.7, P = 0.048). The cutoff value for PLR was determined as 220 according to receiver operating characteristic analysis, with a 63.6% sensitivity and 65.6% specificity.
Conclusion: Although it has limited sensitivity and specificity, decreased preoperative PLR was significantly associated with lymph node metastasis in patients with clinical stages I to II right-sided colon cancer. It should be considered as a biomarker for nodal involvement when planning treatment strategies.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Determinants of lymph node count and positivity in patients undergoing surgery for colon cancer.Medicine (Baltimore). 2018 Mar;97(13):e0185. doi: 10.1097/MD.0000000000010185. Medicine (Baltimore). 2018. PMID: 29595652 Free PMC article.
-
Systemic Inflammatory Biomarkers as Surrogate Markers for Stage in Colon Cancer.Am Surg. 2022 Jun;88(6):1256-1262. doi: 10.1177/0003134821995059. Epub 2021 Feb 17. Am Surg. 2022. PMID: 33596111
-
Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study.Int J Surg. 2018 Aug;56:320-327. doi: 10.1016/j.ijsu.2018.06.037. Epub 2018 Jun 30. Int J Surg. 2018. PMID: 29969732
-
[Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].Zhonghua Wei Chang Wai Ke Za Zhi. 2023 Jul 25;26(7):680-688. doi: 10.3760/cma.j.cn441530-20221018-00415. Zhonghua Wei Chang Wai Ke Za Zhi. 2023. PMID: 37583026 Chinese.
-
Prediction of Lymph Node Metastasis in Colon Cancer via Platelet to Lymphocyte Ratio and Platelet Count.J Coll Physicians Surg Pak. 2020 Mar;30(3):250-253. doi: 10.29271/jcpsp.2020.03.250. J Coll Physicians Surg Pak. 2020. PMID: 32169130
Cited by
-
Unraveling temporal and spatial biomarkers of epithelial-mesenchymal transition in colorectal cancer: insights into the crucial role of immunosuppressive cells.J Transl Med. 2023 Nov 8;21(1):794. doi: 10.1186/s12967-023-04600-x. J Transl Med. 2023. PMID: 37940972 Free PMC article.
References
-
- Cancer 2020 (updated February 2022). Accessed February 3, 2022. https://www.who.int/news-room/fact-sheets/detail/cancer
-
- Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–867.
-
- Nakamura Y, Imada A, Fukugaki A, et al. Association of nutritional risk and systemic inflammation with survival in patients with colorectal cancer who underwent curative surgery. Clin Nutr ESPEN. 2022;49:417–424.
-
- Pine JK, Morris E, Hutchins GG, et al. Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour. Br J Cancer. 2015;113:204–211.
-
- Li Z, Xu Z, Huang Y, et al. Prognostic values of preoperative platelet-to-lymphocyte ratio, albumin, and hemoglobin in patients with non-metastatic colon cancer. Cancer Manag Res. 2019;11:3265–3274.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials